GSK to use Covance’s solutions in global clinical trials portfolio

This article was originally published here

LabCorp’s Covance Drug Development business has signed a strategic technology agreement with GlaxoSmithKline (GSK).

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply